Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,820 | 160 | 92.2% |
| Education | $323.59 | 6 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $844.97 | 52 | $0 (2024) |
| Janssen Biotech, Inc. | $625.56 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $437.16 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $315.60 | 10 | $0 (2024) |
| Amarin Pharma Inc. | $242.42 | 3 | $0 (2019) |
| Celgene Corporation | $172.82 | 13 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $139.04 | 2 | $0 (2018) |
| PFIZER INC. | $127.97 | 9 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $125.00 | 1 | $0 (2022) |
| Valeritas, Inc. | $121.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $672.29 | 31 | Takeda Pharmaceuticals U.S.A., Inc. ($220.45) |
| 2023 | $692.67 | 26 | Janssen Biotech, Inc. ($210.43) |
| 2022 | $864.58 | 47 | ABBVIE INC. ($225.31) |
| 2021 | $709.24 | 41 | AbbVie Inc. ($236.53) |
| 2020 | $318.02 | 8 | AbbVie Inc. ($173.97) |
| 2019 | $456.93 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($190.82) |
| 2018 | $54.63 | 3 | Olympus America Inc. ($26.47) |
| 2017 | $375.64 | 4 | Amarin Pharma Inc. ($130.77) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Immunology | ||||||
| 09/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/17/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Education | In-kind items and services | $12.45 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/07/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Gastroenterology | ||||||
| 03/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/22/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Immunology | ||||||
| 02/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Gastroenterology | ||||||
| 02/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,219 | 1,768 | $339,861 | $191,360 |
| 2022 | 18 | 1,859 | 2,908 | $483,905 | $280,916 |
| 2021 | 19 | 1,889 | 3,164 | $500,662 | $299,243 |
| 2020 | 20 | 1,696 | 2,635 | $383,665 | $222,646 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 471 | 981 | $134,166 | $99,828 | 74.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 185 | 185 | $31,956 | $23,941 | 74.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 107 | 109 | $53,832 | $23,511 | 43.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 116 | 120 | $50,791 | $13,164 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 157 | $14,872 | $11,142 | 74.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 33 | 33 | $12,175 | $6,131 | 50.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 32 | $15,393 | $2,901 | 18.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $7,379 | $2,682 | 36.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 13 | 13 | $4,800 | $2,495 | 52.0% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 52 | 70 | $6,080 | $1,812 | 29.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $5,551 | $1,666 | 30.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $1,725 | $1,194 | 69.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 16 | $1,140 | $894.04 | 78.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 541 | 1,075 | $144,692 | $111,536 | 77.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 237 | 652 | $46,436 | $36,845 | 79.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 187 | 187 | $32,489 | $24,890 | 76.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 100 | 101 | $49,881 | $21,927 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 226 | 269 | $25,884 | $19,317 | 74.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 117 | 135 | $18,271 | $14,441 | 79.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 126 | 128 | $54,144 | $12,893 | 23.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 37 | 40 | $14,758 | $5,664 | 38.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 54 | 56 | $18,284 | $5,518 | 30.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 29 | 29 | $11,491 | $5,444 | 47.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 31 | $6,167 | $4,913 | 79.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 30 | 30 | $14,431 | $3,412 | 23.6% |
About Dr. Jose Suatengco, MD
Dr. Jose Suatengco, MD is a Gastroenterology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518932615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Suatengco, MD has received a total of $4,144 in payments from pharmaceutical and medical device companies, with $672.29 received in 2024. These payments were reported across 166 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,820).
As a Medicare-enrolled provider, Suatengco has provided services to 6,663 Medicare beneficiaries, totaling 10,475 services with total Medicare billing of $994,165. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Toms River, NJ
- Active Since 02/22/2006
- Last Updated 01/17/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1518932615
Products in Payments
- STELARA (Biological) $558.31
- Vascepa (Drug) $242.42
- GATTEX (Drug) $218.20
- XIFAXAN (Drug) $190.21
- MAVYRET (Drug) $188.55
- LINZESS (Drug) $182.23
- TREMFYA (Drug) $179.94
- ENTYVIO (Biological) $179.69
- ZEPOSIA (Drug) $172.82
- ZENPEP (Drug) $131.02
- XELJANZ (Drug) $127.97
- TRULANCE (Drug) $125.39
- RAYALDEE (Drug) $125.00
- FARXIGA (Drug) $124.34
- DUPIXENT (Biological) $124.32
- V-GO (Device) $121.17
- Livalo (Drug) $120.53
- SKYRIZI (Biological) $118.68
- EVENITY (Biological) $114.19
- HUMIRA (Biological) $77.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Toms River
Mr. Neil Nagaria, Md, MD
Gastroenterology — Payments: $18,349
Teresa Tacopina, Md, MD
Gastroenterology — Payments: $7,735
Dr. Eric Eschinger, Md, MD
Gastroenterology — Payments: $6,236
Kenneth Glazier
Gastroenterology — Payments: $5,912
Carl Raso, Md, MD
Gastroenterology — Payments: $5,227
Gabrielle Corpuz, Pa-C, PA-C
Gastroenterology — Payments: $4,258